A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study (Q42170053)
Jump to navigation
Jump to search
scientific article published on June 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study |
scientific article published on June 2009 |
Statements
1 reference
A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study (English)
1 reference
Kiat Ruxrungtham
1 reference
Somnuek Sungkanuparph
1 reference
Weerawat Manosuthi
1 reference
Preecha Tantanathip
1 reference
Aroon Lueangniyomkul
1 reference
Wiroj Mankatitham
1 reference
Wisit Prasithsirskul
1 reference
Sunantha Burapatarawong
1 reference
Supeda Thongyen
1 reference
Sirirat Likanonsakul
1 reference
Unchana Thawornwa
1 reference
Vilaiwan Prommool
1 reference
N2R Study Team
1 reference
1 June 2009
1 reference
1 reference
Identifiers
1 reference